EP2331080A4 - Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques - Google Patents

Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques

Info

Publication number
EP2331080A4
EP2331080A4 EP09806994A EP09806994A EP2331080A4 EP 2331080 A4 EP2331080 A4 EP 2331080A4 EP 09806994 A EP09806994 A EP 09806994A EP 09806994 A EP09806994 A EP 09806994A EP 2331080 A4 EP2331080 A4 EP 2331080A4
Authority
EP
European Patent Office
Prior art keywords
deter
pharmaceutical compositions
dosage form
compositions configured
form splitting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09806994A
Other languages
German (de)
English (en)
Other versions
EP2331080A1 (fr
Inventor
Manish S Shah
Ray J Difalco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inspirion Delivery Technologies LLC
Original Assignee
Inspirion Delivery Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2008/072914 external-priority patent/WO2009023672A2/fr
Application filed by Inspirion Delivery Technologies LLC filed Critical Inspirion Delivery Technologies LLC
Publication of EP2331080A1 publication Critical patent/EP2331080A1/fr
Publication of EP2331080A4 publication Critical patent/EP2331080A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
EP09806994A 2008-08-12 2009-02-12 Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques Withdrawn EP2331080A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2008/072914 WO2009023672A2 (fr) 2007-08-13 2008-08-12 Médicaments résistant aux abus, procédés d'utilisation et de fabrication
PCT/US2009/033919 WO2010019279A1 (fr) 2008-08-12 2009-02-12 Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques

Publications (2)

Publication Number Publication Date
EP2331080A1 EP2331080A1 (fr) 2011-06-15
EP2331080A4 true EP2331080A4 (fr) 2012-11-07

Family

ID=41674715

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09806994A Withdrawn EP2331080A4 (fr) 2008-08-12 2009-02-12 Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques

Country Status (4)

Country Link
EP (1) EP2331080A4 (fr)
AU (1) AU2009282376A1 (fr)
CA (1) CA2734075C (fr)
WO (1) WO2010019279A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007048220A2 (fr) 2005-09-09 2007-05-03 Labopharm Inc. Composition de trazodone a administration quotidienne
AU2011346758C1 (en) 2010-12-23 2015-09-03 Purdue Pharma L.P. Tamper resistant solid oral dosage forms
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117841A1 (fr) * 2004-05-28 2005-12-15 Bristol-Myers Squibb Company Formulation de comprime revetu et procede correspondant
WO2009023672A2 (fr) * 2007-08-13 2009-02-19 Abuse Deterrent Pharmaceutical Llc Médicaments résistant aux abus, procédés d'utilisation et de fabrication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050163843A1 (en) * 2003-12-31 2005-07-28 Garth Boehm Alprazolam formulations
WO2007013975A2 (fr) * 2005-07-20 2007-02-01 Pharmorx Inc. Compositions et procedes destines a controler l'abus de medicaments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117841A1 (fr) * 2004-05-28 2005-12-15 Bristol-Myers Squibb Company Formulation de comprime revetu et procede correspondant
WO2009023672A2 (fr) * 2007-08-13 2009-02-19 Abuse Deterrent Pharmaceutical Llc Médicaments résistant aux abus, procédés d'utilisation et de fabrication

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2010019279A1 *

Also Published As

Publication number Publication date
WO2010019279A1 (fr) 2010-02-18
EP2331080A1 (fr) 2011-06-15
CA2734075A1 (fr) 2010-02-18
CA2734075C (fr) 2017-04-18
AU2009282376A1 (en) 2010-02-18
WO2010019279A8 (fr) 2011-03-17

Similar Documents

Publication Publication Date Title
ZA201005015B (en) Solid pharmaceutical dosage form
ZA201006029B (en) Pharmaceutical dosage form
EP2240022A4 (fr) Compositions pharmaceutiques
GB0814695D0 (en) Pharmaceutical compositions
IL228817A0 (en) Pharmaceutical compounds
EP2373681A4 (fr) Compositions pharmaceutiques
PT2323623T (pt) Composições farmacêuticas
HU0900072D0 (en) Transdermal pharmaceutical compositions
HK1161552A1 (en) Pharmaceutical topical compositions
ZA200903858B (en) Pharmaceutical dosage form
ZA201102715B (en) Solid pharmaceutical composition
EP2468771A4 (fr) Composition pharmaceutique contenant un anticorps anti-hb-egf comme ingrédient actif
IL208387A0 (en) Pharmaceutical composition
IL219617A0 (en) Pharmaceutical solid dosage form
GB0815852D0 (en) Improvements relating to pharmaceutical compositions
ZA201100871B (en) Solid pharmaceutical composition
IL208788A (en) Pharmacy-based formulation
EP2296687A4 (fr) Compositions pharmaceutiques de conjugués somatostatine-dopamine
ZA201006224B (en) Pharmaceutical composition
EP2331080A4 (fr) Compositions pharmaceutiques configurées pour dissuader le fractionnement des formes posologiques
GB2464200B (en) Pharmaceutical composition
IL206487A0 (en) Pharmaceutical compositions
GB0817969D0 (en) Pharmaceutical composition
HK1182939A1 (en) Stable pharmaceutical composition
GB0800659D0 (en) Pharmaceutical Compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110314

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INSPIRION DELIVERY TECHNOLOGIES, LLC

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121010

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/485 20060101ALI20121004BHEP

Ipc: A61K 9/20 20060101ALI20121004BHEP

Ipc: A61K 9/22 20060101AFI20121004BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130509